SEEGENE
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls 2020-09-08 20:00
Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls 2020-09-08 20:00
Seegene Allplex(TM) 2019-nCoV Assay (SARS-CoV-2) Gets Expanded FDA Emergency Use Authorization 2020-07-30 19:00
Seegene Exports 10 million Corona Tests to Brazil 2020-05-18 21:59
Seegene's Allplex™ 2019-nCoV Assay receives FDA Emergency Use Authorization 2020-04-22 07:40
Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries 2020-04-20 20:00
Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries 2020-04-20 20:00
Seegene Receives Health Canada Approval for its COVID-19 Assay 2020-04-13 21:00
Seegene launches KFDA Approved COVID-19 Assay 2020-02-18 08:00
Seegene Highlights Clinical Automated Nucleic Acid Extraction System at ASM Microbe 2019 2019-06-21 20:00
Seegene Establishes Brazilian Subsidiary 2019-06-18 19:00
Seegene launches a new anti-microbial drug resistance test kit, replacing the conventional culture method 2018-11-26 21:00
Seegene Unveils New Real-time PCR Analysis Technology, Drastically Increasing Its Multiplexing Capacity 2018-09-19 20:00
1 2 3 4